Isis Pharmaceuticals (NASDAQ:ISIP) and the 91±¬ÁÏ (91±¬ÁÏ) School of Medicine. have announced today that Isis has joined 91±¬ÁÏ’s Cell Systems Initiative (CSI). CSI is a research and educational program whose mission is to understand the dynamic information systems in cells.
March 20, 2000